Michelle A. Josephson

Michelle Josephson practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Michelle Josephson's NPI, 1184785917, was assigned on December 13, 2006. Michelle Josephson graduated from Perelman School of Med at the University of Pennsylvania in 1983. Michelle Josephson holds Illinois license 036069523.

Michelle Josephson's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Michelle Josephson's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Michelle Josephson is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Michelle Josephson to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michelle Josephson practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Michelle Josephson's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Michelle Josephson is licensed in Illinois.

CMS data shows 420 Medicare services from Michelle Josephson across 5 procedure codes in 2024, for 180 Medicare patients. Medicare paid $45,017 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 180 Medicare patients who saw Michelle Josephson in 2024. The largest group is under 65, with 92 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 52% are also on Medicaid. Their average risk score is 7.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michelle Josephson's median patient age at 63, with 46% women.

In 2024, Michelle Josephson wrote 793 Medicare Part D claims for 174 patients. 93% of them were for generic drugs. CMS names the drug for 547 of them, across 18 drugs with 11 or more claims each, at $28,307 in total drug cost. In 2023, CMS named 776 claims across 23 drugs.

Michelle Josephson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michelle Josephson as offering telehealth.

Dmand AI links 10 papers to Michelle Josephson, published from 2023 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Kidney Transplantation, Immunosuppressive Agents and Hypertension. Michelle Josephson's most frequent co-authors are Rolf N. Barth, Deborah B. Adey, MD and Piotr Jerzy Bachul, MD.

Dmand AI links Michelle Josephson to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Autoimmune Diseases, Hepadnaviridae Infections and Hepatitis B. Open Payments lists research payments to Michelle Josephson that name 2 trials.

CMS Open Payments shows 45 general payments to Michelle Josephson from 17 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 40% of the total. Alexion Pharmaceuticals, Inc. paid the most, $12,310. It also lists 5 research payments totaling $1,944 from 2018 to 2022, naming 2 clinical trials.

Michelle Josephson graduated from Perelman School of Med at the University of Pennsylvania in 1983.